1 Min Read
May 10 (Reuters) - Nabriva Therapeutics AG
* Nabriva Therapeutics reports first quarter 2017 financial results
* Q1 loss per share $5.60 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.